Antibiotic-resistant bacteria pose a major challenge to healthcare systems worldwide. Due to numerous resistance mechanisms, infections with the pathogen Pseudomonas aeruginosa are particularly feared. Researchers have now discovered antibodies that could lead to a highly potent treatment option of acute and chronic infections with P. aeruginosa.
